Schreiber RD - Search Results

1

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.

Gubin MM, Zhang X, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber WJ, Mulder GE, Toebes M, Vesely MD, Lam SS, Korman AJ, Allison JP, Freeman GJ, Sharpe AH, Pearce EL, Schumacher TN, Aebersold R, Rammensee HG, Melief CJ, Mardis ER, Gillanders WE, Artyomov MN, Schreiber RD. Gubin MM, et al. Among authors: schreiber rd. Nature. 2014 Nov 27;515(7528):577-81. doi: 10.1038/nature13988. Nature. 2014. PMID: 25428507 Free PMC article.

2

Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.

Sheehan KC, Pinckard JK, Arthur CD, Dehner LP, Goeddel DV, Schreiber RD. Sheehan KC, et al. Among authors: schreiber rd. J Exp Med. 1995 Feb 1;181(2):607-17. doi: 10.1084/jem.181.2.607. J Exp Med. 1995. PMID: 7836916 Free PMC article.

3

Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice.

Erickson SL, de Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N, Sheehan KC, Schreiber RD, Goeddel DV, Moore MW. Erickson SL, et al. Among authors: schreiber rd. Nature. 1994 Dec 8;372(6506):560-3. doi: 10.1038/372560a0. Nature. 1994. PMID: 7990930

4

Constitutive shedding of both p55 and p75 murine TNF receptors in vivo.

Pinckard JK, Sheehan KC, Arthur CD, Schreiber RD. Pinckard JK, et al. Among authors: schreiber rd. J Immunol. 1997 Apr 15;158(8):3869-73. J Immunol. 1997. PMID: 9103455

5

Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses.

Rodig SJ, Meraz MA, White JM, Lampe PA, Riley JK, Arthur CD, King KL, Sheehan KC, Yin L, Pennica D, Johnson EM Jr, Schreiber RD. Rodig SJ, et al. Among authors: schreiber rd. Cell. 1998 May 1;93(3):373-83. doi: 10.1016/s0092-8674(00)81166-6. Cell. 1998. PMID: 9590172 Free article.

6

Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.

Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, Schreiber RD. Yin L, et al. Among authors: schreiber rd. Science. 2001 Mar 16;291(5511):2162-5. doi: 10.1126/science.1058453. Science. 2001. PMID: 11251123

7

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.

Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD. Shankaran V, et al. Among authors: schreiber rd. Nature. 2001 Apr 26;410(6832):1107-11. doi: 10.1038/35074122. Nature. 2001. PMID: 11323675

8

Cancer immunoediting: from immunosurveillance to tumor escape.

Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Dunn GP, et al. Among authors: schreiber rd. Nat Immunol. 2002 Nov;3(11):991-8. doi: 10.1038/ni1102-991. Nat Immunol. 2002. PMID: 12407406 Review.

9

A critical function for type I interferons in cancer immunoediting.

Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD. Dunn GP, et al. Among authors: schreiber rd. Nat Immunol. 2005 Jul;6(7):722-9. doi: 10.1038/ni1213. Epub 2005 Jun 12. Nat Immunol. 2005. PMID: 15951814

10

Breaking down the barriers to cancer immunotherapy.

Puré E, Allison JP, Schreiber RD. Puré E, et al. Among authors: schreiber rd. Nat Immunol. 2005 Dec;6(12):1207-10. doi: 10.1038/ni1205-1207. Nat Immunol. 2005. PMID: 16369561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters